After a successful 1st edition, the 2nd Young Scientist Cancer Congress is taking place on October 10 and 11 2024. The congress topic, « New Translational Approaches in Cancer Therapy », will bring together basic, computational and clinician scientists.
Aim: promote the work of postdocs and young clinician scientists, optimize their career paths, establish networks, and enable new translational research projects.
Public: the conference is open to the whole scientific community, which are researchers and clinicians of all career levels.
Organization: This day will alternate presentations by internationally renowned keynote speakers, presentations by postdocs and young clinicians, application-focused presentations by 2 leading single-cell and spatial transcriptomics companies and a presentation from an editor of Nature Communications about scientific publishing and peer-reviewing.
Keynote speakers
- Frances Balkwill (Barts Cancer Institute, UK)
- Nicholas MacGranahan (University College London, UK)
- Mara Sherman (Memorial Sloan Kettering Cancer Center, USA)
- Daniela Thommen (The Netherlands Cancer Institute, NL)
- Michael Schmück-Henneresse (Berlin Institute of Health, D)
- Charles Herbaux (CHU de Montpellier, F)
- Joanne Clancy (Nature Communications, UK)
The physician’s corner: a dedicated space for informal meetings between clinicians and researchers will be proposed.
The call for abstracts is for young scientists only, ie PhD students, postdocs & young clinicians. A selection committee of GSO postdocs/young clinicians will select the best abstracts for oral presentations and posters. An EACR prize for the best oral communication will also be awarded.
Venue: Auditorium Dumontet of University of Montpellier. Registration is for free, but mandatory.